Article Information
History
- July 12, 2021.
Article Versions
- Version 1 (December 11, 2020 - 05:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Ivayla Roberts1,
- Marina Wright Muelas1,†,
- Joseph M. Taylor2,
- Andrew S. Davison2,
- Yun Xu1,3,
- Justine M. Grixti1,
- Nigel Gotts1,3,
- Anatolii Sorokin1,
- Royston Goodacre1,3 and
- Douglas B. Kell1,4,†
- 1Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK
- 2Department of Clinical Biochemistry and Metabolic Medicine, Liverpool Clinical Laboratories, Royal Liverpool University Hospitals Trust, Liverpool, UK
- 3Centre for Metabolomics Research (CMR), Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK
- 4Novo Nordisk Foundation Centre for Biosustainability, Technical University of Denmark, Building 220, Chemitorvet, Kgs Lyngby 2000, Denmark
- ↵†Corresponding authors Dr. Marina Wright Muelas (m.wright-muelas{at}liverpool.ac.uk), Prof. Douglas B. Kell (douglas.kell{at}liverpool.ac.uk)
Posted July 12, 2021.
Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome
